Cerebral Infarction in Tuberculous Meningitis in Adults: A Systematic Review
DOI:
https://doi.org/10.65310/mn36d110Kata Kunci:
Adult patients, Cerebral infarction, Neuroimaging, Systematic review, Tuberculous meningitisAbstrak
Cerebral infarction is a major neurological complication of tuberculous meningitis (TBM) in adults, potentially contributing to neurological deterioration and long-term disability. This systematic review aimed to examine cerebral infarction frequency and anatomical patterns, associated clinical and inflammatory factors, neuroimaging findings, and therapeutic interventions reporting vascular outcomes. A structured PubMed search covered publications from 2016 to 2026, with searches conducted between October 3 and November 4, 2026. Primary studies involving adults were selected through predefined eligibility criteria, critically appraised using relevant National Heart, Lung, and Blood Institute methodological domains, and synthesized qualitatively without meta-analysis. Among 234 identified records, 66 reports were sought for retrieval, 35 full texts were assessed, and 11 primary studies were included; 31 reports could not be retrieved. Reported cerebral infarction frequencies ranged from 20.0% to 81.0% across selected populations, with substantial clinical and methodological heterogeneity. Infarction frequently involved the basal ganglia, while older age, focal neurological deficits, cerebrospinal fluid inflammatory characteristics, and meningeal enhancement showed associations of uncertain predictive validity. Magnetic resonance imaging, angiography, venography, and perfusion techniques provided complementary vascular information. Two randomized trials failed to establish definitive benefits of adjunctive antiplatelet therapy. These findings support integrated neurological and imaging assessment while highlighting insufficient evidence for routine antiplatelet prevention and the need for standardized prospective investigations.
Unduhan
Referensi
Abdelgawad, N., Wasserman, S., Abdelwahab, M. T., et al. (2024). Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis. The Journal of Infectious Diseases, 229(4), 1200–1208. https://doi.org/10.1093/infdis/jiad413
Aggrohia, A., Bhatia, V., Saroch, A., & Pannu, A. K. (2024). Predicting cerebral infarction in tuberculous meningitis and its prognostic significance. Biomarkers in Medicine, 18(8), 407–417. https://doi.org/10.1080/17520363.2024.2347194
Bhatia, R., Shree, R., Modi, M., Anand, A., Garg, A., Haldar, P., Padma Srivastava, M. V., Singla, N., Goyal, M., Supriya, S., Sharma, K., Wig, N., Singh, M. B., Fatima, S., Longkumer, I., Bindal, T., Srivastava, A., Vishnu, V. Y., Biswas, A., … Ahuja, C. (2025). A randomised trial to assess the efficacy of add on therapy with aspirin or clopidogrel to the standard medical therapy alone in patients with tubercular meningitis: ACT TBM. The Lancet Regional Health - Southeast Asia, 37, 100604. https://doi.org/10.1016/j.lansea.2025.100604
Campbell, M., McKenzie, J. E., Sowden, A., Katikireddi, S. V., Brennan, S. E., Ellis, S., Hartmann-Boyce, J., Ryan, R., Shepperd, S., Thomas, J., Welch, V., & Thomson, H. (2020). Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ, 368, l6890. https://doi.org/10.1136/bmj.l6890
Cantier, M., Morisot, A., Guérot, E., Megarbane, B., Razazi, K., Contou, D., Mariotte, E., Canet, E., De Montmollin, E., Dubée, V., Boulet, E., Gaudry, S., Voiriot, G., Mayaux, J., Pène, F., Neuville, M., Mourvillier, B., Ruckly, S., Bouadma, L., … ENCEPHALITICA study group. (2018). Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study. Critical Care, 22(1), 210. https://doi.org/10.1186/s13054-018-2140-8
Colas, R. A., Nhat, L. T. H., Thuong, N. T. T., Gómez, E. A., Ly, L., Thanh, H. H., Mai, N. T. H., Phu, N. H., Thwaites, G. E., & Dalli, J. (2019). Proresolving mediator profiles in cerebrospinal fluid are linked with disease severity and outcome in adults with tuberculous meningitis. The FASEB Journal, 33(11), 13028-13039. https://doi.org/10.1096/fj.201901590R
Deng, X., Huang, Q., Huang, H., Chen, S., Wang, X., & Liang, Z. (2025). Tuberculous meningitis-related ischemic stroke: A retrospective study from a tertiary care hospital. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 38, 100508. https://doi.org/10.1016/j.jctube.2024.100508
Deswal, S., Qavi, A., Singh, A. K., Maurya, P. K., Kulshreshtha, D., & Ansari, A. (2026). Inflammatory biomarkers as predictors of paradoxical reaction in tubercular meningitis: A prospective observational study. BMJ Neurology Open, 8(2), e001750. https://doi.org/10.1136/bmjno-2026-001750
Dian, S., Koeken, V. A. C. M., Ardiansyah, E., et al. (2025). Inflammatory markers in the cerebrospinal fluid linked to mortality in tuberculous meningitis. Brain Communications, 7(4), fcaf273. https://doi.org/10.1093/braincomms/fcaf273
Donovan, J., Bang, N. D., Imran, D., et al. (2023). Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults. The New England Journal of Medicine, 389(15), 1357–1367. https://doi.org/10.1056/NEJMoa2216218
Donovan, J., Cresswell, F. V., Tucker, E. W., Davis, A. G., Rohlwink, U. K., Huynh, J., Solomons, R., Seddon, J. A., Bahr, N. C., van Laarhoven, A., Anderson, S. T., Jain, S. K., Chow, F. C., Pattison, S., Scriven, J. E., Singh, G., Aarnoutse, R. E., Alffenaar, J. C., Dian, S., … Thwaites, G. E. (2026). A clinical practice guideline for tuberculous meningitis. The Lancet Infectious Diseases, 26(2), e96-e111. https://doi.org/10.1016/S1473-3099(25)00364-0
Fei, Z.-T., Huang, W., Zhou, D.-P., et al. (2025). Clinical efficacy of linezolid in the treatment of tuberculous meningitis: A retrospective analysis and literature review. BMC Infectious Diseases, 25, 467. https://doi.org/10.1186/s12879-025-10874-x
Garg, R. K. (2026). Updates in the clinical management of tuberculous meningitis. Expert Review of Anti-infective Therapy, 24(3), 337–354. https://doi.org/10.1080/14787210.2025.2579210
Harahap, M. I. R., Soetikno, R. D., & Anwary, F. (2023). Relationship between neutrophil count in cerebrospinal fluid and cerebral infarct appearance in head MRI on tuberculous meningitis patients. European Journal of Radiology Open, 10, 100469. https://doi.org/10.1016/j.ejro.2022.100469
Imron, A., Hermanto, Y., Rizal, A., Yunivita, V., & Ruslami, R. (2025). Cerebrospinal fluid analysis in tuberculous meningitis: A literature review. Surgical Neurology International, 16, 246. https://doi.org/10.25259/SNI_1131_2024
Kumar, S., & Gutch, M. (2020). Advanced Magnetic Resonance Imaging Techniques in Tuberculous Meningitis. Advanced Biomedical Research, 9, 20. https://doi.org/10.4103/abr.abr_222_19
Lamb, G., van Crevel, R., Meintjes, G., & Davis, A. (2026). Ischaemia in tuberculous meningitis: Update on pathophysiology, clinical predictors and management. Current Opinion in Infectious Diseases, 39(3), 179–188. https://doi.org/10.1097/QCO.0000000000001194
Mai, N. T. H., Dobbs, N., Phu, N. H., Colas, R. A., Thao, L. T. P., Thuong, N. T. T., Nghia, H. D. T., Hanh, N. H. H., Hang, N. T., Heemskerk, A. D., Day, J. N., Ly, L., Thu, D. D. A., Merson, L., Kestelyn, E., Wolbers, M., Geskus, R., Summers, D., Chau, N. V. V., … Thwaites, G. E. (2018). A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults. eLife, 7, e33478. https://doi.org/10.7554/eLife.33478
Mertiri, L., Freiling, J. T., Desai, N. K., Kralik, S. F., & Huisman, T. A. G. M. (2024). Pediatric and adult meningeal, parenchymal, and spinal tuberculosis: A neuroimaging review. Journal of Neuroimaging, 34(2), 179–194. https://doi.org/10.1111/jon.13177
Naik, S., Bhoi, S. K., Deep, N., Mohakud, S., Mishra, B., Dey, A., Kumar, R., Saharia, G. K., & Kumar, M. (2022). Vascular Manifestations of Tuberculous Meningitis: MR Angiography and Venography Study. Journal of Neurosciences in Rural Practice, 13(3), 529-536. https://doi.org/10.1055/s-0042-1748175
National Heart, Lung, and Blood Institute. (n.d.). Study quality assessment tools. Retrieved November 4, 2026, from https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
Pandey, P. C., Kalita, J., & Shukla, R. (2024). Predictors of resolution of meningitis symptoms in tuberculous meningitis: A clinical, magnetic resonance imaging, and biomarker study. The American Journal of Tropical Medicine and Hygiene, 111(2), 251–258. https://doi.org/10.4269/ajtmh.23-0312
Sahu, S. K., Dhamija, R. K., Maheshwari, S., Panda, A. K., DungDung, A. A., Khurana, S., Chaturvedi, M., & Maheshwari, S. (2026). Clinical Profile and Prognostic Determinants in Central Nervous System Tuberculosis: An Observational Study from a Tertiary Neurology Centre in India. Annals of Indian Academy of Neurology, 29(2), 217-221. https://doi.org/10.4103/aian.aian_1063_25
Saluja, A., Vibha, D., Pandit, A. K., et al. (2023). Comparison of dexamethasone regimens in tubercular meningitis (TBM): A randomized open label clinical trial. Journal of Infection in Developing Countries, 17(12), 1769–1774. https://doi.org/10.3855/jidc.17563
Tang, S., Liu, L., Xie, Z., He, Y., Zhang, Y., Xie, Y., Chen, S., Liu, Y., Wei, Y., & Liang, Z. (2022). Acute Ischemic Stroke in Tubercular Meningitis Patients Without Conventional Vascular Risk Factors: A Retrospective Case Control Study. Journal of Inflammation Research, 15, 6617-6627. https://doi.org/10.2147/JIR.S392040
Tomidy, J., Satriadinatha, G. B. Y., Liwang, F. K., Maharani, K., Imran, D., & Estiasari, R. (2023). Prognostic identifier of cerebrovascular complications in tuberculous meningitis: Meta-analysis. Journal of Stroke and Cerebrovascular Diseases, 32(11), 107371. https://doi.org/10.1016/j.jstrokecerebrovasdis.2023.107371
Tugume, L., Cresswell, F. V., Engen, N. W., et al. (2025). Prognostic value of C-reactive protein in adults with tuberculous meningitis: A prospective cohort study. Clinical Infectious Diseases, 81(5), e410–e413. https://doi.org/10.1093/cid/ciaf261
Wang, Y., Xu, Z., Xu, D., & Hou, D. (2026). Quantitative ASL perfusion and vessel wall MRI in tuberculous meningitis: A pre- and post-treatment study. Journal of Clinical Medicine, 15(2), 424. https://doi.org/10.3390/jcm15020424
Zhang, L., Zhang, X., Li, H., Chen, G., & Zhu, M. (2019). Acute ischemic stroke in young adults with tuberculous meningitis. BMC Infectious Diseases, 19(1), 362. https://doi.org/10.1186/s12879-019-4004-5
Zhu, X., He, N., Tong, L., Gu, Z. H., & Li, H. (2023). Clinical characteristics of tuberculous meningitis in older patients compared with younger and middle-aged patients: a retrospective analysis. BMC Infectious Diseases, 23(1), 699. https://doi.org/10.1186/s12879-023-08700-3
Unduhan
Diterbitkan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Mangde Anata Sindhu (Author)

Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.



















